Form 13-F position report

ELEVANCE HEALTH INC FORMERLY

Reported by Ruane Cunniff & Goldfarb L P

ELV CUSIP 036752103 Manager CIK 0001720792

Reported 974,621 shares, down 4,977 (0.5%) from the prior quarter.

Reported value 0.0%; share count -0.5% vs. the prior quarter.

Reduced
% of reported 13F value 6.17% This manager · Q3 2026
Shares 974,621 Quarter-end amount reported
Reported value $378,952,137 Fair value at quarter end
Consecutive quarters held 23 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 820484000
2022-03-31 863284000
2022-06-30 489330000
2022-09-30 448724000
2022-12-31 423981503
2023-03-31 371123687
2023-06-30 465903820
2023-09-30 500829228
2023-12-31 528921973
2024-03-31 557267160
2024-06-30 554903112
2024-09-30 522357160
2024-12-31 422004262
2025-03-31 488425283
2025-06-30 426165969
2025-09-30 467969203
2025-12-31 498659478
2026-03-31 406327632
2026-06-30 378839935
2026-09-30 378952137

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for ELEVANCE HEALTH INC FORMERLY held by Ruane Cunniff & Goldfarb L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 974,621 -4,977 (-0.5%) 6.17% $378,952,137 2026-11-13
Q2 2026 Reduced 979,598 -408,370 (-29.4%) 5.89% $378,839,935 2026-08-14
Q1 2026 Reduced 1,387,968 -34,538 (-2.4%) 6.74% $406,327,632 2026-05-15
Q4 2025 Reduced 1,422,506 -25,777 (-1.8%) 7.79% $498,659,478 2026-02-13
Q3 2025 Added 1,448,283 +352,628 (32.2%) 7.75% $467,969,203 2025-11-14
Q2 2025 Reduced 1,095,655 -27,265 (-2.4%) 7.31% $426,165,969 2025-08-14
Q1 2025 Reduced 1,122,920 -21,033 (-1.8%) 8.87% $488,425,283 2025-05-15
Q4 2024 Added 1,143,953 +139,420 (13.9%) 7.16% $422,004,262 2025-02-14
Q3 2024 Reduced 1,004,533 -19,538 (-1.9%) 8.17% $522,357,160 2024-11-14
Q2 2024 Reduced 1,024,071 -50,614 (-4.7%) 8.65% $554,903,112 2024-08-14
Q1 2024 Reduced 1,074,685 -46,958 (-4.2%) 8.65% $557,267,160 2024-05-15
Q4 2023 Reduced 1,121,643 -28,578 (-2.5%) 8.45% $528,921,973 2024-02-14
Q3 2023 Added 1,150,221 +101,573 (9.7%) 8.31% $500,829,228 2023-11-14
Q2 2023 Added 1,048,648 +241,524 (29.9%) 7.35% $465,903,820 2023-08-14
Q1 2023 Reduced 807,124 -19,399 (-2.3%) 6.06% $371,123,687 2023-05-15
Q4 2022 Reduced 826,523 -161,334 (-16.3%) 6.62% $423,981,503 2023-02-13
Q3 2022 Reduced 987,857 -26,130 (-2.6%) 6.67% $448,724,000 2022-11-14
Q2 2022 Reduced 1,013,987 -743,441 (-42.3%) 6.38% $489,330,000 2022-08-15
Q1 2022 Reduced 1,757,428 -12,612 (-0.7%) 8.5% $863,284,000 2022-05-13
Q4 2021 Reduced 1,770,040 -51,373 (-2.8%) 7.01% $820,484,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1746 managers reported ELEVANCE HEALTH INC FORMERLY for Q3 2026.

Managers reporting ELEVANCE HEALTH INC FORMERLY in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Added 19,523,886 +532,796 0.11% $7,591,277,244 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 13,823,409 -234,795 0.11% $5,374,817,887 3 qtrs
STATE STREET CORPORATION Added 10,493,831 +67,221 0.12% $4,080,211,369 44 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 8,516,420 -697,093 0.59% $3,311,354,424 48 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Reduced 6,204,274 -10,082 0.11% $2,412,345,817 3 qtrs
Sanders Capital LLC Added 5,830,605 +5,581 2.2% $2,267,055,836 48 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 5,216,506 +50,382 0.1% $2,019,246,207 48 qtrs
Invesco Ltd Added 5,068,202 +833,971 0.15% $1,970,618,428 48 qtrs
HARRIS ASSOCIATES L P Reduced 4,778,654 -145,857 2.42% $1,858,036,272 8 qtrs
First Eagle Investment Management LLC Added 4,198,657 +10,461 2.56% $1,632,521,706 48 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 13, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
972,476
Shared
0
None
2,145

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.